Metabolism-Clinical and Experimental

Papers
(The H4-Index of Metabolism-Clinical and Experimental is 48. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Editorial Board619
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications523
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults400
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History189
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multic187
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset177
Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4167
Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men159
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity155
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors153
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review135
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy109
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice108
The role of active vitamin D in preventing sarcopenia—Authors' reply96
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states95
Hearing loss in inherited metabolic disorders: A systematic review95
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis95
Brown adipose tissue-derived metabolites and their role in regulating metabolism95
PCSK9 in metabolism and diseases92
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity89
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy86
Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake86
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models81
Association between hypertension and severity of NAFLD among adults with obesity75
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus74
Editorial Board74
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R73
Editorial Board73
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications69
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]69
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients67
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study65
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men64
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease63
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics61
Exosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy59
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-1958
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease57
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells55
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease54
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity53
Role of mitochondria in pathogenesis and therapy of renal fibrosis53
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review53
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis50
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis50
Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia49
Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic49
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies48
NPRC promotes hepatic steatosis via USP30-mediated deubiquitination of C/EBPβ48
Editorial Board48
A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts48
0.16429805755615